Cardiovascular diseases are the leading cause of death worldwide, representing 32% of all global deaths1. With almost 45 million people facing slight or marked limitation of physical activity due to chronic heart failure2, 3, early detection becomes paramount in this cardiovascular condition. FORESEE is here to reshape the landscape.
Heart failure patients decompensate with time, leading to repeated hospitalizations with serious consequences: about 50% of patients die within five years4. It also accounts for a massive economic burden, estimated in US$108 billion worldwide each year5.
These patients require not just follow-up, but also proactive care.
Embrace a new era in heart failure management with FORESEE. Our innovative microsensing platform can sense multiple parameters from a single intravascular device, providing a more complete view of the patient’s condition.
1 World Health Organization. Cardiovascular diseases. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
2 Eur J Prev Cardiol. 2021 Dec 29;28(15):1682-1690.
3 Clin Res Cardiol. 2017; 106(11): 913–922.
4 Circulation. 2021 Feb 23;143(8):e254-e743.
5 Int J Cardiol. 2014 Feb 15;171(3):368-76.
This project has received funding from the European Union’s HORIZON-EIC-2023-TRANSITIONOPEN program under grant agreement No 101136633. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union and the Agency. Neither the European Union nor the granting authority can be held responsible for them.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.